BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 15.3//EN
BEGIN:VTIMEZONE
TZID:Eastern Standard Time
BEGIN:STANDARD
DTSTART:20251102T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11
TZNAME:Eastern Standard Time
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:Eastern Daylight Time
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:About The WebinarThe new Section 232 tariffs on pharmaceuticals
  raise broader legal\, compliance\, and supply chain considerations for co
 mpanies operating in this sector. This webinar will examine what these mea
 sures may mean for manufacturers\, importers\, and downstream market parti
 cipants. Our speaker will discuss the practical challenges companies may f
 ace in assessing exposure\, managing compliance risk\, and planning for op
 erational disruption\, as well as what steps companies can take to respond
 .Key TopicsExplanation of the new Section 232 tariffs on pharmaceuticalsKe
 y compliance and reporting considerations triggered by Section 232 trade a
 ctionsCompliance considerations for companies navigating heightened trade 
 and enforcement scrutinyhttps://www.strtrade.com/training/events/upcoming-
 webinars/understanding-section-232-trade-actions-in-the-pharmaceutical-sec
 tor&nbsp\;
DTEND:20260430T190000Z
DTSTAMP:20260421T233736Z
DTSTART:20260430T180000Z
LOCATION:
SEQUENCE:0
SUMMARY:STR Webinar: Understanding Section 232 Trade Actions in the Pharmac
 eutical Sector
UID:RFCALITEM639124114566480887
X-ALT-DESC;FMTTYPE=text/html:<div>About The Webinar</div><div>The new Secti
 on 232 tariffs on pharmaceuticals raise broader legal\, compliance\, and s
 upply chain considerations for companies operating in this sector. This we
 binar will examine what these measures may mean for manufacturers\, import
 ers\, and downstream market participants. Our speaker will discuss the pra
 ctical challenges companies may face in assessing exposure\, managing comp
 liance risk\, and planning for operational disruption\, as well as what st
 eps companies can take to respond.</div><div>Key Topics</div><div>Explanat
 ion of the new Section 232 tariffs on pharmaceuticals</div><div>Key compli
 ance and reporting considerations triggered by Section 232 trade actions</
 div><div><p>Compliance considerations for companies navigating heightened 
 trade and enforcement scrutiny</p><p><a href="https://www.strtrade.com/tra
 ining/events/upcoming-webinars/understanding-section-232-trade-actions-in-
 the-pharmaceutical-sector">https://www.strtrade.com/training/events/upcomi
 ng-webinars/understanding-section-232-trade-actions-in-the-pharmaceutical-
 sector</a>&nbsp\;</p></div>
END:VEVENT
END:VCALENDAR